Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-25-003228

Chief Commercial Officer acquired 183,067 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Grow Brian Chief Commercial Officer 2025-02-19 Grant or award +183,067 670,490 D
Derivatives
Grow Brian Chief Commercial Officer 2025-02-19 Grant or award · Stock Option (Right to Buy) +189,369 189,369 D
Loading xslF345X05/form4.xml…